Latest

neuropsychopharmacology

The image shows how neurons function with SSRIs.

Featured Psychology

·June 21, 2013·2 min read

Compound Enhances SSRI Antidepressant’s Effects in Mice

A synthetic compound, decynium-22, is able to turn off SERT in the brain, enhancing the effectiveness of SSRIs.

The image shows neurons in a subsection of the adult rat hippocampus. The caption best describes the image.

Electrophysiology Featured

·May 30, 2013·4 min read

Ketamine Cousin Rapidly Lifts Depression Without Side Effects

A new study funded by the NIMH suggests GLYX-13, a molecular cousin to ketamine, induces similar antidepressant results without the negative side effects of the well known street drug.

Featured Psychology

·February 6, 2013·2 min read

Induction of Mild Inflammation Leads to Cognitive Deficits Related to Schizophrenia

Researchers have identified an exceptional mouse model of schizophrenia. The study identified a mutant mouse lacking the Schnurri-2 protein (Shn-2 KO) that exhibits behavioral deficits and other brain features consistent with schizophrenia.

Featured Neuroscience

·October 16, 2012·3 min read

Attack! Silent Watchmen Charge to Defend the Nervous System

Research provides the first evidence that mechanisms regulated by the Runx1 gene control the balance between the surveillant versus activated microglia states.

Featured Neurology Neuroscience

·July 23, 2012·3 min read

Synthetic Stimulants Called Bath Salts Act in the Brain Like Cocaine

Results of a new study offer compelling evidence for the first time that mephedrone, like cocaine, does have potential for abuse and addiction. “The effects of mephedrone on the brain’s reward circuits are comparable to similar doses of cocaine,” Dr. Malanga, a professor of neurology, pediatrics and psychology at UNC School of Medicine said. “As expected our research shows that mephedrone likely has significant abuse liability.”